Growth Metrics

Novartis Ag (NVS) EPS (Weighted Average and Diluted) (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -47.54%
Sep 30, 2023 109.33%
Jun 30, 2023 -70.40%
Mar 31, 2023 159.66%
Dec 31, 2022 -52.04%
Sep 30, 2022 -96.04%
Jun 30, 2022 381.10%
Mar 31, 2022 7.27%
Dec 31, 2021 197.61%
Sep 30, 2021 -93.11%
Jun 30, 2021 383.84%
Mar 31, 2021 -59.50%
Dec 31, 2020 500.33%
Sep 30, 2020 -92.70%
Jun 30, 2020 1,458.11%
Mar 31, 2019 -2,649.90%
Dec 31, 2018 90.88%
Sep 30, 2018 -535.74%
Jun 30, 2018 -82.39%
Mar 31, 2018 -56.26%
Dec 31, 2017 -35.19%
Sep 30, 2017 -91.27%
Jun 30, 2017 273.31%
Mar 31, 2017 23,181.52%
Dec 31, 2016 -98.54%
Sep 30, 2016 -70.54%
Jun 30, 2016 239.03%
Mar 31, 2016 31,614.35%
Dec 31, 2015 -97.96%
Sep 30, 2015 141,735,072.68%
Jun 30, 2015 -104.35%
Mar 31, 2015 347.62%
Dec 31, 2014 -636.42%
Sep 30, 2014 131.02%
Jun 30, 2014 -125.28%
Sep 30, 2013 402.14%
Sep 30, 2012 -40.13%
Jun 30, 2012 -47.06%
Mar 31, 2012 109.90%
Dec 31, 2011 61.81%
Sep 30, 2011 -67.68%
Jun 30, 2011 -14.94%
Mar 31, 2011 402.21%
Dec 31, 2010 -36.44%
Sep 30, 2010 -58.33%
Jun 30, 2010 -83.80%
Mar 31, 2010 1,007,457.24%
Dec 31, 2009 -21.42%
Sep 30, 2009 -65.56%
Jun 30, 2009 -0.04%